Scancell Holdings PLC
Scancell Holdings PLC
#06564638 • Active
B2bPhysical ProductServices
Scancell is a clinical stage biopharmaceutical company dedicated to developing innovative immunotherapies that harness the body's immune system to combat cancer and infectious diseases. Their proprietary research focuses on creating novel vaccines and monoclonal antibodies targeting specific protein modifications.
Founded: 14/04/2008
Industries: Other research and experimental development on natural sciences and engineeringOther human health activities
Website: https://scancell.co.uk
Phone: Subscribe to view
Location: Oxford
Products
- Avidimab® Antibody Enhancement Platform
- Glymab® Monoclonal Antibodies
- Immunobody® Vaccines
- Moditope® Cancer Vaccines
Services
- Immunotherapy Development
- Monoclonal Antibody Production
- Vaccine Development
Financial Snapshot
Last accounts made up to 30 April 2024
Next accounts due 31 October 2025 (5 months)
Cash in Bank £14.82m
↓ -26%
EBITDA -£17.3m
↓ 62%
Total Liabilities £6.39m
↓ -20%
Employees 61
↑ 20%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Phillip John L’huillier | Chief Executive Officer | 18/11/2024 | New Zealander | 63 years |
| Florian Nicolas Christian Reinaud | Managing Director | 09/07/2024 | French | 51 years |
| Sathijeevan Nirmalananthan | Chartered Accountant | 14/03/2024 | British | 39 years |
| Jean-michel Cossery | Company Director | 01/02/2023 | French | 65 years |
| Susan Elizabeth Clement Davies | Financier | 24/09/2020 | British | 62 years |
| Ursula Mary Ney | Director | 23/10/2019 | British | 73 years |
| Martin Henry Diggle | Investor | 18/06/2019 | British | 63 years |
| Linda Gillian Durrant | Scientist | 16/04/2008 | British | 67 years |
Role:
Chief Executive Officer
Appointed:
18/11/2024
Nationality:
New Zealander
Age:
63 years
Role:
Managing Director
Appointed:
09/07/2024
Nationality:
French
Age:
51 years
Role:
Chartered Accountant
Appointed:
14/03/2024
Nationality:
British
Age:
39 years
Role:
Company Director
Appointed:
01/02/2023
Nationality:
French
Age:
65 years
Role:
Financier
Appointed:
24/09/2020
Nationality:
British
Age:
62 years
Role:
Director
Appointed:
23/10/2019
Nationality:
British
Age:
73 years
Role:
Investor
Appointed:
18/06/2019
Nationality:
British
Age:
63 years
Role:
Scientist
Appointed:
16/04/2008
Nationality:
British
Age:
67 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Jeremy Charles Green | Ownership Of Shares 25 To 50 Percent | 02/11/2020 | British |
Jeremy Charles Green
Nature of Control:
Ownership Of Shares 25 To 50 Percent
Notified On:
02/11/2020
Nationality:
British
Financial Accounts
| Apr 2024 | Apr 2023 | Apr 2022 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
No charges registered
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 17/04/2025 | Officers | Change Person Director Company With Change Date | View (2 pages) |
| 17/12/2024 | Capital | Capital Allotment Shares | View (3 pages) |
| 21/11/2024 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 03/11/2024 | Resolution | Resolution | View (2 pages) |
| 31/10/2024 | Accounts | Accounts With Accounts Type Group | View (66 pages) |
| 02/08/2024 | Capital | Second Filing Capital Allotment Shares | View (4 pages) |
| 24/07/2024 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |